SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS) and a provider of guidance and decision support for genomic medicine, today announced four new health plan clients that are implementing DNA Direct's Policy & Benefit Support Program for molecular diagnostic and genetic tests. The program enables payors to determine coverage for more than 800 molecular diagnostic and genetic tests and provides real time access to the DNA Direct team of clinical experts for clinical guidance on more than 2,000 tests available today.
Qualchoice of Arkansas, Inc., and Capital District Physicians Health Plan, based in New York, are the first regional plans to implement the program. DNA Direct also provides case review support utilizing its team of genetic experts to provide health plans with on demand coverage guidance. AultCare, based in Ohio, and Bluegrass Family Health, based in Kentucky, are implementing the case review service of the program.
"Molecular diagnostic and genetic testing represents a multi-billion dollar market and is growing at a rapid pace," said Ryan Phelan, Founder & President of DNA Direct. "Due to the increasing number of genetic tests coming on the market, there is confusion among physicians, patients, and payors about which tests are clinically appropriate. We are working with innovative health plans that want to get ahead of the curve and implement an effective strategy to provide the necessary clinical guidance and support for providers and patients."
There are more than 2,000 diseases for which molecular diagnostic and genetic tests are available today, with more than 300 tests becoming available each year. DNA Direct's Policy & Benefi